CVS CVS Health
Consumer Defensive · Retail-Drug Stores And Proprietary Stores
CVS Health (CVS) is a consumer defensive company in the Retail-Drug Stores And Proprietary Stores industry, with a market capitalization of $125.4 billion. Shares last traded at $98.32, 4.3% below their 52-week high. Over the past year the stock is up 46.7%. CVS trades at a price-to-earnings ratio of 70.96, in line with the Retail-Drug Stores And Proprietary Stores median of 70.96. Net profit margin is 0.4%, above the peer median of -0.2%. Revenue grew 7.8% year over year. The shares yield 4.1% in dividends.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q1 2026 | $2.30 | 2026-05-06 |
| FY 2025 | $1.39 | 2026-02-10 |
| Q3 2025 | $-0.93 | 2025-10-29 |
| Q2 2025 | $2.21 | 2025-07-31 |
| Q1 2026 | $1.41 | 2026-05-06 |
| FY 2025 | $3.66 | 2026-02-10 |
Retail-Drug Stores And Proprietary Stores peers
CVS vs 5 industry peers (Retail-Drug Stores And Proprietary Stores), by market cap.
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.